Nuo Therapeutics, Inc.
AURX
$1.24
$0.010.78%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.11% | 2.01% | 8.24% | 21.93% | 26.73% |
| Total Depreciation and Amortization | 62.93% | 50.58% | 21.23% | -5.14% | -8.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 662.46% | -24.55% | -58.96% | -75.51% | -83.57% |
| Change in Net Operating Assets | 3,485.56% | 858.52% | 551.72% | 331.55% | 87.74% |
| Cash from Operations | 61.24% | 61.33% | 73.76% | 43.18% | 29.55% |
| Capital Expenditure | -77.29% | -49.42% | -6,275.00% | -20,157.89% | -2,052.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -77.29% | -49.42% | -6,275.00% | -20,157.89% | -2,052.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -48.04% | -61.92% | -66.44% | -12.81% | -12.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -19.33% | -61.92% | -66.44% | -12.81% | -12.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 141.11% | -465.23% | -312.62% | 66.92% | 45.23% |